During a mean follow-up of 9.6 months, adults receiving an SGLT2 inhibitor had a lower risk for a CV event than those receiving a GLP-1 receptor agonist (HR = 0.92
Most GLP-1 medications are administered via subcutaneous injection , either daily or weekly depending on the specific formulation, though oral semaglutide (Rybelsus) is available for type 2 diabetes
Drugs they make aren't generics rather they buy ingredients from Food and Drug Administration-registered suppliers and prepare finished versions for patients with prescriptions specifically for compounded medicines
Patients who have taken excessive doses typically experience severe and persistent nausea, often accompanied by repeated vomiting that may lead to inability to maintain oral hydration or nutrition
Metabolism 113 , 154388 (2020)
Injection Site Reactions: Redness, pain, or swelling at the injection site is possible